MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 74 filers reported holding MARRONE BIO INNOVATIONS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | 0.0% | 1,130 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -66.7% | 1,130 | -68.9% | 0.00% | – |
Q4 2021 | $3,000 | 0.0% | 3,630 | 0.0% | 0.00% | – |
Q3 2021 | $3,000 | -50.0% | 3,630 | 0.0% | 0.00% | – |
Q2 2021 | $6,000 | +50.0% | 3,630 | +81.5% | 0.00% | – |
Q1 2021 | $4,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARDSLEY ADVISORY PARTNERS LP | 10,323,247 | $16,425,000 | 2.21% |
ICM ASSET MANAGEMENT INC/WA | 262,900 | $481,000 | 0.34% |
WADDELL & REED FINANCIAL INC | 24,714,892 | $45,228,000 | 0.10% |
THOMPSON DAVIS & CO., INC. | 10,000 | $18,000 | 0.04% |
Whitegate Investment Counselors, Inc. | 15,000 | $27,000 | 0.01% |
Tower Research Capital LLC (TRC) | 22,728 | $42,000 | 0.00% |
PRIMECAP MANAGEMENT CO/CA/ | 2,625,600 | $4,805,000 | 0.00% |
Allworth Financial LP | 10,766 | $20,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 78,906 | $144,000 | 0.00% |
NORTHERN TRUST CORP | 524,475 | $959,000 | 0.00% |